Ignite Creation Date:
2025-12-25 @ 12:34 AM
Ignite Modification Date:
2026-02-11 @ 12:29 PM
Study NCT ID:
NCT01811667
Status:
COMPLETED
Last Update Posted:
2016-04-14
First Post:
2012-10-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of the Mammalian Target of Rapamycin (mTor Rapamycin) Inhibitor in Vascular Malformations
Sponsor:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
vasca-LM
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None